Capital Management Corp VA Acquires 1,496 Shares of CME Group Inc. (NASDAQ:CME)

Capital Management Corp VA increased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 4.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 34,568 shares of the financial services provider’s stock after purchasing an additional 1,496 shares during the period. Capital Management Corp VA’s holdings in CME Group were worth $7,627,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Salomon & Ludwin LLC bought a new position in shares of CME Group during the 1st quarter worth about $28,000. Y.D. More Investments Ltd bought a new position in CME Group in the second quarter worth approximately $36,000. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC raised its position in shares of CME Group by 515.2% during the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its holdings in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Price Performance

Shares of NASDAQ CME opened at $223.08 on Tuesday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The stock has a market cap of $80.33 billion, a PE ratio of 23.46, a price-to-earnings-growth ratio of 5.62 and a beta of 0.55. The stock has a fifty day moving average of $220.98 and a 200-day moving average of $209.58.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the company earned $2.25 earnings per share. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. Equities research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. CME Group’s payout ratio is currently 48.37%.

Insider Buying and Selling

In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the transaction, the director now directly owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on CME. Citigroup upped their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Redburn Atlantic cut CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research report on Tuesday, October 8th. The Goldman Sachs Group increased their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Oppenheimer upped their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.